ABT vs AAPL: Which Stock is Better?
Side-by-side comparison of Abbott Laboratories and Apple Inc in 2026
Comparison Updated:
ABT
Abbott Laboratories
$124.64
AAPL
Apple Inc
$260.25
Key Metrics Comparison
| Metric | ABT | AAPL | Winner |
|---|---|---|---|
| Market Cap | $219.16B | $3.83T | AAPL |
| P/E Ratio | 15.82 | 34.72 | ABT |
| EPS (TTM) | $7.96 | $7.47 | ABT |
| Revenue Growth | 0.1% | 0.1% | AAPL |
| Gross Margin | 56.3% | 46.9% | ABT |
Analyze ABT
Full quant analysis
Analyze AAPL
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is ABT or AAPL a better investment?
Comparing ABT and AAPL: Abbott Laboratories has a market cap of $219.16B while Apple Inc has $3.83T. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between ABT and AAPL?
ABT (Abbott Laboratories) and AAPL (Apple Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: ABT or AAPL?
Based on P/E ratios, ABT trades at a lower multiple (15.8x vs 34.7x).